GoodRx Holdings, Inc.

NASDAQ:GDRX

Medical - Healthcare Information Services

Healthcare
$3.36 +1.72%

+$0.05 today

Market cap
$1.15B
Beta
1.61
P/E (TTM)
44.0
EPS (TTM)
$0.06
52W Low $1.77High $5.81

Volume 0.66M

Average 1.61M

GDRX Net Income

Bottom-line profit, the starting point for calculating cash from operations.

GoodRx Holdings, Inc.NASDAQ: GDRX

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income declines year over year

Q1 FY2026 net income of $1.17M fell 89.4% year over year, behind the -27.7% change in trailing-twelve-month net income. Sequentially, it fell 78.5% from the prior quarter.

Context

  • Net income amounted to 3.8% of revenue in FY2025, up 1.8 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 10 analysts of $102.79M (+237.7%) for the fiscal year ending Dec 2026, a step up from the +85.7% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.17M-78.5% QoQ
Last fiscal yearDec 2025
$30.44M+85.7% YoY
LTMMar 2026
$20.56M-27.7% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-89.4%+116.0%+205.4 pp
1 year+85.7%+237.7%+152.0 pp
3-year CAGR—+62.4%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
30.44M USD
Year-over-year change
+85.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How GDRX compares with its peers on the latest reported figures

  • GDRX's LTM Mar 2026 net income of $20.56M is the 3rd largest of the 4 companies compared; the peer median is $86.67M.
  • Its year-over-year change of -27.7% is the 2nd highest of 4, against a peer median of -44.1%.
  • Net income amounts to 2.6% of revenue for GDRX, versus a peer median of 6.8%.
GDRX Competitors Peer median
Net Income for GDRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TDOCTeladoc Health, Inc.LTM Mar 2026$171.15M -83.1%-75.5%6.8%
AMWLAmerican Well CorporationLTM Mar 2026$86.67M -44.1%-29.4%36.5%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$20.56M -27.7%—2.6%
LFMDLifeMD, Inc.LTM Mar 2026$507.37K +105.0%—0.2%
Peer median (excluding GDRX) $86.67M-44.1%-52.5%6.8%

Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(25.25M)(32.83M)(8.87M)16.39M30.44M
Depreciation & Amortization34.54M54.18M111.77M69.54M85.22M
Deferred Income Tax12.85M(497K)(65.56M)(11.91M)20.07M
Stock-Based Compensation160.46M120.23M104.82M99.03M76.63M
Change in Working Capital(11.8M)(20.29M)(21.94M)2.09M(56.44M)
Accounts Receivables(43.95M)1.38M(26.47M)(2.33M)(88.02M)
Inventory00000
Accounts Payables4.21M(874K)17.46M(21.24M)4.1M
Other Working Capital27.95M(20.79M)(12.93M)25.66M27.47M
Other Non-Cash Items7.98M25.98M18.07M8.76M11.99M
Operating Cash Flow178.78M146.78M138.29M183.89M167.9M
Capital Expenditures(34.46M)(55.21M)(55.77M)(70.35M)(3.52M)
Acquisitions (Net)(144.28M)(155.28M)00(30M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(29.89M)(51.25M)(54.72M)(70.35M)(87.68M)
Investing Cash Flow(178.73M)(210.5M)(55.77M)(70.35M)(119.96M)
Debt Repayment(7.03M)(7.03M)(5.27M)(167.01M)(3.75M)
Common Stock Issued00000
Common Stock Repurchased0(101.72M)(103.97M)(158.85M)(206.94M)
Dividends Paid00000
Other Financing Activities(23.5M)(11.48M)(58.15M)(11.65M)(23.78M)
Financing Cash Flow(30.53M)(120.23M)(167.4M)(337.5M)(234.47M)
Effect of Forex Changes00000
Net Change in Cash(30.48M)(183.94M)(84.87M)(223.95M)(186.53M)
Free Cash Flow144.32M91.57M82.53M113.55M164.38M

GoodRx Holdings, Inc.

NASDAQ:GDRX

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.